Cost Effectiveness of Human Immunodeficiency Virus Postexposure Prophylaxis for Healthcare Workers

Author： Scheid D.C.   Hamm R.M.   Stevens K.W.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.18, Iss.4, 2000-10, pp. : 355-368

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Post-Exposure Influenza Prophylaxis with Oseltamivir: Cost Effectiveness and Cost Utility in Families in the UK

By Sander Beate  

PharmacoEconomics, Vol. 24, Iss. 4, 2006-01 ,pp. : 373-386

Adis International

Access to resources Recommend Favorite

Oseltamivir cost effective for post-exposure prophylaxis of influenza

By  

Inpharma, Vol. 1, Iss. 1537, 2006-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Respiratory Syncytial Virus Prophylaxis: A Critical and Systematic Review

By PrescottJr William A.   Doloresco Fred   Brown Jack   Paladino Joseph A.  

PharmacoEconomics, Vol. 28, Iss. 4, 2010-04 ,pp. : 279-293

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Palivizumab for Respiratory Syncytial Virus Prophylaxis in High-Risk Children: A UK Analysis

By Nuijten Mark J.C.   Wittenberg Wolfgang   Lebmeier Maximilian  

PharmacoEconomics, Vol. 25, Iss. 1, 2007-01 ,pp. : 55-71

Adis International

Access to resources Recommend Favorite

HIV and postexposure prophylaxis

By Benn Paul   Fisher Martin  

Clinical Medicine, Vol. 8, Iss. 3, 2008-06 ,pp. : 319-322

Royal College Of Physicians

Access to resources Recommend Favorite